搜索临床试验以:14C 标记的 ACT-541468
总计100个结果
-
Idorsia Pharmaceuticals Ltd.终止
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of Alexion完全的
-
Idorsia Pharmaceuticals Ltd.完全的
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)未知
-
Astellas Pharma Inc完全的健康 | Pharmacokinetics of ASP1585美国
-
Astellas Pharma Global Development, Inc.完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)招聘中
-
AstraZeneca完全的
-
Narendranath Epperla撤销复发性边缘区淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 难治性边缘区淋巴瘤 | 难治性淋巴结边缘区淋巴瘤 | 复发性淋巴结边缘区淋巴瘤 | 复发性脾边缘区淋巴瘤 | 难治性脾边缘区淋巴瘤 | 难治性惰性非霍奇金淋巴瘤
-
AstraZeneca完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)招聘中
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的